GSK PLC (GSK)
43.10
+0.10
(+0.24%)
USD |
NYSE |
Mar 28, 10:33
GSK Price: 43.10 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 42.58 | 43.03 | 42.51 | 42.99 | 2.076M |
Mar 26, 2024 | 42.83 | 42.89 | 42.55 | 42.79 | 3.042M |
Mar 25, 2024 | 42.58 | 43.45 | 42.56 | 42.83 | 3.437M |
Mar 22, 2024 | 42.54 | 42.68 | 42.33 | 42.35 | 1.483M |
Mar 21, 2024 | 42.17 | 42.54 | 42.15 | 42.37 | 2.024M |
Mar 20, 2024 | 42.02 | 42.04 | 41.75 | 41.93 | 1.799M |
Mar 19, 2024 | 42.24 | 42.33 | 42.07 | 42.32 | 1.999M |
Mar 18, 2024 | 42.21 | 42.35 | 42.14 | 42.14 | 1.346M |
Mar 15, 2024 | 42.28 | 42.43 | 41.81 | 42.19 | 4.130M |
Mar 14, 2024 | 43.21 | 43.26 | 42.81 | 43.08 | 1.843M |
Mar 13, 2024 | 43.27 | 43.37 | 43.08 | 43.36 | 1.678M |
Mar 12, 2024 | 42.93 | 43.27 | 42.80 | 43.27 | 2.197M |
Mar 11, 2024 | 42.88 | 42.96 | 42.73 | 42.92 | 2.515M |
Mar 08, 2024 | 43.02 | 43.22 | 42.91 | 43.14 | 3.308M |
Mar 07, 2024 | 43.68 | 43.84 | 43.48 | 43.58 | 4.382M |
Mar 06, 2024 | 42.38 | 42.71 | 42.33 | 42.62 | 3.247M |
Mar 05, 2024 | 42.63 | 42.78 | 42.49 | 42.60 | 2.635M |
Mar 04, 2024 | 42.04 | 42.44 | 42.02 | 42.44 | 2.404M |
Mar 01, 2024 | 42.01 | 42.08 | 41.78 | 42.03 | 2.325M |
Feb 29, 2024 | 42.65 | 42.69 | 41.80 | 41.90 | 4.381M |
Feb 28, 2024 | 42.35 | 42.44 | 42.13 | 42.34 | 4.041M |
Feb 27, 2024 | 42.12 | 42.44 | 42.07 | 42.38 | 3.734M |
Feb 26, 2024 | 42.52 | 42.58 | 42.25 | 42.34 | 3.023M |
Feb 23, 2024 | 42.35 | 42.45 | 42.14 | 42.22 | 3.441M |
Feb 22, 2024 | 41.65 | 42.24 | 41.63 | 42.16 | 6.180M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
28.66
Minimum
Sep 27 2022
58.56
Maximum
Apr 13 2022
40.82
Average
40.26
Median
Price Benchmarks
AstraZeneca PLC | 68.10 |
Haleon PLC | 8.54 |
Novo Nordisk A/S | 129.31 |
Sanofi SA | 49.37 |
Moderna Inc | 109.51 |
Price Related Metrics
PE Ratio | 15.42 |
PS Ratio | 2.488 |
Price to Book Value | 5.143 |
Price to Free Cash Flow | 17.06 |
Earnings Yield | 6.49% |
Market Cap | 87.44B |
Operating PE Ratio | 10.28 |
Normalized PE Ratio | 14.09 |